Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding

Justin A. Jarrell, Amy A. Twite, Katherine H. W. J. Lau, Moein Navvab Kashani, Adrian A. Lievano, Julyana Acevedo, Craig Priest, Jorge J. Nieva, David Gottlieb, Ryan S. Pawell

Abstract

Abstract Intracellular delivery of functional macromolecules, such as DNA and RNA, across the cell membrane and into the cytosol, is a critical process in both biology and medicine. Herein, we develop and use microfluidic chips containing post arrays to induce microfluidic vortex shedding , or μVS , for cell membrane poration that permits delivery of mRNA into primary human T lymphocytes. We demonstrate transfection with μVS by delivery of a 996-nucleotide mRNA construct encoding enhanced green fluorescent protein (EGFP) and assessed transfection efficiencies by quantifying levels of EGFP protein expression. We achieved high transfection efficiency (63.6 ± 3.44% EGFP+ viable cells) with high cell viability (77.3 ± 0.58%) and recovery (88.7 ± 3.21%) in CD3+ T cells 19 hrs after μVS processing. Importantly, we show that processing cells via μVS does not negatively affect cell growth rates or alter cell states. We also demonstrate processing speeds of greater than 2.0 × 10 6 cells s −1 at volumes ranging from 0.1 to 1.5 milliliters. Altogether, these results highlight the use of μVS as a rapid and gentle delivery method with promising potential to engineer primary human cells for research and clinical applications.
BibTeX
@inproceedings{jarrell2019intracellular,
  author = {Justin A. Jarrell and Amy A. Twite and Katherine H. W. J. Lau and Moein Navvab Kashani and Adrian A. Lievano and Julyana Acevedo and Craig Priest and Jorge J. Nieva and David Gottlieb and Ryan S. Pawell},
  title = {{Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-40147-y},
}
Figure